Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

13 Pharmas Sign Roadmap For Antibiotic Reform – But What Do They Want?

Executive Summary

More than 13 global pharma companies, including GlaxoSmithKline, Pfizer and Merck & Co., have agreed a "Roadmap" aimed at relieving the growing antimicrobial resistance crisis worldwide – as well as principles to explore alternative business models and incentives for antibiotic R&D and reimbursement.

Advertisement

Related Content

O'Neill Warns Pharma Risks Backlash If Doesn't Engage In World AMR Pact
Jim O’Neill Is “Free For Global AMR Role” After Leaving UK Government
Jim O’Neill Is “Free For Global AMR Role” After Leaving UK Government
Pharma Warns On O'Neill Levy Idea But Wants To Join Global AMR Fight
Video Interview: QureTech Bio Explains Novel Approach To Antibiotic Development

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097333

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel